US Enlists Small Biotech for Experimental Ebola Treatment (2)

US officials are working with a small biotech company to provide an experimental treatment that may be used in patients exposed to Ebola, according to a person familiar with the matter.

The closely held firm, Mapp Biopharmaceutical Inc., is working with the Biomedical Advanced Research and Development Authority, or BARDA, to deliver its drug for potential use in patients, said the person, who asked not to be identified.

Mapp, based in San Diego, focuses on developing vaccines and treatments for infectious diseases. The company had an experimental drug for Ebola that was given to a few American aid workers ...